153 related articles for article (PubMed ID: 34944637)
1. Prostaglandin F2 and EP2 Agonists Exert Different Effects on 3D 3T3-L1 Spheroids during Their Culture Phase.
Ida Y; Furuhashi M; Watanabe M; Umetsu A; Hikage F; Ohguro H
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944637
[TBL] [Abstract][Full Text] [Related]
2. Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.
Ida Y; Watanabe M; Umetsu A; Ohguro H; Hikage F
Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102315. PubMed ID: 34246925
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.
Ida Y; Watanabe M; Ohguro H; Hikage F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925005
[TBL] [Abstract][Full Text] [Related]
4. Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells.
Ida Y; Hikage F; Umetsu A; Ida H; Ohguro H
Sci Rep; 2020 Sep; 10(1):16018. PubMed ID: 32994409
[TBL] [Abstract][Full Text] [Related]
5. Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs).
Hikage F; Ichioka H; Watanabe M; Umetsu A; Ohguro H; Ida Y
Hum Cell; 2022 Jan; 35(1):125-132. PubMed ID: 34591280
[TBL] [Abstract][Full Text] [Related]
6. Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts.
Hikage F; Ida Y; Ouchi Y; Watanabe M; Ohguro H
Transl Vis Sci Technol; 2021 Apr; 10(4):6. PubMed ID: 34003984
[TBL] [Abstract][Full Text] [Related]
7. Unexpected Crosslinking Effects of a Human Thyroid Stimulating Monoclonal Autoantibody, M22, with IGF1 on Adipogenesis in 3T3L-1 Cells.
Umetsu A; Sato T; Watanabe M; Ida Y; Furuhashi M; Tsugeno Y; Ohguro H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674625
[TBL] [Abstract][Full Text] [Related]
8. The EP2 agonist, omidenepag, alters the physical stiffness of 3D spheroids prepared from human corneal stroma fibroblasts differently depending on the osmotic pressure.
Ida Y; Umetsu A; Furuhashi M; Watanabe M; Hikage F; Ohguro H
FASEB J; 2022 Jan; 36(1):e22067. PubMed ID: 34914140
[TBL] [Abstract][Full Text] [Related]
9. Brimonidine Modulates the ROCK1 Signaling Effects on Adipogenic Differentiation in 2D and 3D 3T3-L1 Cells.
Umetsu A; Ida Y; Sato T; Watanabe M; Tsugeno Y; Furuhashi M; Hikage F; Ohguro H
Bioengineering (Basel); 2022 Jul; 9(7):. PubMed ID: 35877378
[TBL] [Abstract][Full Text] [Related]
10. Screening of the Drug-Induced Effects of Prostaglandin EP2 and FP Agonists on 3D Cultures of Dexamethasone-Treated Human Trabecular Meshwork Cells.
Watanabe M; Ida Y; Furuhashi M; Tsugeno Y; Ohguro H; Hikage F
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440134
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Effects of a Selective EP2 Agonist, Omidenepag, and a Rho-Associated Coiled-Coil Containing Protein Kinase Inhibitor, Ripasudil, on Human Orbital Fibroblasts.
Hikage F; Watanabe M; Sato T; Umetsu A; Tsugeno Y; Furuhashi M; Ohguro H
J Ocul Pharmacol Ther; 2023 Sep; 39(7):439-448. PubMed ID: 37352418
[No Abstract] [Full Text] [Related]
12. Addition of ROCK Inhibitors Alleviates Prostaglandin-Induced Inhibition of Adipogenesis in 3T3L-1 Spheroids.
Ida Y; Sato T; Umetsu A; Watanabe M; Furuhashi M; Hikage F; Ohguro H
Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36421103
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.
Ichioka H; Ida Y; Watanabe M; Ohguro H; Hikage F
Exp Eye Res; 2021 Apr; 205():108489. PubMed ID: 33587909
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
Yamamoto Y; Taniguchi T; Inazumi T; Iwamura R; Yoneda K; Odani-Kawabata N; Matsugi T; Sugimoto Y; Shams NK
J Ocul Pharmacol Ther; 2020 Apr; 36(3):162-169. PubMed ID: 31934812
[No Abstract] [Full Text] [Related]
15. Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells.
Suzuki S; Furuhashi M; Tsugeno Y; Umetsu A; Ida Y; Hikage F; Ohguro H; Watanabe M
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329980
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin F2α agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix.
Ida Y; Hikage F; Itoh K; Ida H; Ohguro H
Sci Rep; 2020 May; 10(1):7958. PubMed ID: 32409724
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin F2α agonists induced enhancement in collagen1 expression is involved in the pathogenesis of the deepening of upper eyelid sulcus.
Itoh K; Ida Y; Ohguro H; Hikage F
Sci Rep; 2021 Apr; 11(1):9002. PubMed ID: 33903711
[TBL] [Abstract][Full Text] [Related]
18. ROCK inhibitors modulate the physical properties and adipogenesis of 3D spheroids of human orbital fibroblasts in different manners.
Hikage F; Ichioka H; Watanabe M; Umetsu A; Ohguro H; Ida Y
FASEB Bioadv; 2021 Oct; 3(10):866-872. PubMed ID: 34632320
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid FP and EP2 Receptor Agonists Induce Epithelial and Subepithelial Fibrogenetic Changes in Human Conjunctival Fibroblasts in Different Manners.
Tsugeno Y; Sato T; Watanabe M; Furuhashi M; Ohguro H
J Ocul Pharmacol Ther; 2023 Jul; 39(6):404-414. PubMed ID: 37459581
[No Abstract] [Full Text] [Related]
20. Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.
Ida Y; Ichioka H; Furuhashi M; Hikage F; Watanabe M; Umetsu A; Ohguro H
Cells; 2021 Nov; 10(11):. PubMed ID: 34831419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
